Products are supplied for research use only.
NOVAGENIXLABORATORIES Verify a vial

Research peptides, independently analysed

Novagenix Laboratories produces lyophilised peptides for research use. Every lot is tested by an independent laboratory, and the certificate is linked to each vial through a unique code.

A Novagenix Retatrutide 60 mg vial with its label and QR code
Retatrutide 60 mg · lot 2604-RET60-A · certificate NSK-2026-04817

From synthesis to vial

Peptides are built on resin by Fmoc solid-phase synthesis, cleaved, purified by preparative reversed-phase HPLC and lyophilised. Each lot is then tested once by an independent laboratory; every vial in it carries its own code.

  1. Synthesis

    Fmoc/tBu solid-phase synthesis assembles the sequence residue by residue on the resin. Cleavage with TFA and precipitation in cold ether give the crude peptide: the target sequence among its deletion and truncation products.

  2. Purification

    Preparative reversed-phase HPLC on C18 with a water–acetonitrile gradient isolates the target. Pooled fractions are lyophilised to a dry powder and filled by weight into single vials.

  3. Release

    An independent laboratory measures chromatographic purity (RP-HPLC-UV, 214 nm), identity (high-resolution ESI-Q-TOF MS) and content against a USP reference standard. The lot is released against its certificate; each vial then receives a unique code.

Figure 1 — Crude product after cleavage; the purified fraction; the released lot, one code per vial.

Analytical data

Released lots and their certificates. The values are those reported by Novosibirsk Analytics; each certificate carries its own verification link, so every number here can be checked at the source.

Table 1 and the methods were transcribed from certificates dated 2026-08-20; page updated 2026-10-19.

Certificate of analysis NSK-2026-04816 from Novosibirsk Analytics for GHK-Cu lot 2604-GHK100-A: 99.841 % purity
Certificate NSK-2026-04816 — GHK-Cu, lot 2604-GHK100-A

Product list

Research peptides and compounds, lyophilised, supplied in packs of ten vials. Sizes are per vial. Sequence, formula, molecular weight and CAS number refer to the free peptide unless a salt is stated; a residue in brackets carries the stated modification. The 2026 catalogue carries catalogue numbers, pack sizes and terms.

Release specification

What every lot must meet before it is released, with the results of the three certified lots (reports NSK-2026-04815, -04816 and -04817, Novosibirsk Analytics).

Method uncertainty ± 2.0 % as stated on the certificates. Storage: 2–8 °C, lyophilised, protected from light. Lot and expiry are printed on every label.

Vial verification

Each vial carries a unique 12-character code, NX-XXXXX-XXXXX, printed under its QR. The verification page returns the product, the lot, the certificate number and how many times that code has been checked before.

  • The code is printed under the QR on every vial label; the QR encodes novagenixlaboratories.com/v/‹code› and opens the same page.
  • The record shows the product, the lot number, the certificate of analysis and the number of previous scans.
  • A code that returns no record, or an unexpectedly high scan count, should be reported to the laboratory before the vial is used.

Verify a vial

The check runs on novagenixlaboratories.com/verify/ and records the scan.

Quality and compliance

How a lot is released, how a vial stays traceable, and the documents that go with them.

Novagenix vials in a steel rack on a laboratory bench, an HPLC system and a laminar-flow hood behind
Filled vials ahead of release testing

Independent release testing

Each lot is analysed by Novosibirsk Analytics — chromatographic purity by RP-HPLC-UV, identity by ESI-Q-TOF high-resolution MS, content against a USP reference standard — before it is released. Certificates are published at the laboratory's own address and linked from every vial code.

Lot coding and traceability

Every vial carries a unique code tied to its lot number, certificate and scan history. The lot number names the synthesis month, the product and the series (2604-GHK100-A: April 2026, GHK-Cu 100 mg, series A) and is printed on the label.

Documents

Research use onlyAll materials are supplied strictly for laboratory and research purposes and are not intended for human or veterinary use, diagnosis or treatment. The buyer is responsible for compliance with the import, handling and regulatory requirements of their jurisdiction.
Storage and handlingLyophilised vials: 2–8 °C, protected from light; lot and expiry are printed on every label. Reconstitute with bacteriostatic or sterile water as listed under Solvents and accessories.

About Novagenix Laboratories

Novagenix Laboratories synthesises and lyophilises peptides for research. Products are supplied to laboratories and to authorised distributors; they are not medicines and are not sold as such.

Release testing is performed by Novosibirsk Analytics, an independent laboratory. Each certificate carries its own verification link, so a result can be checked at the source rather than on this site.

We do not publish ordering numbers on this site. Supply goes through authorised distributors only. To confirm that a seller is authorised, write to info@novagenixlaboratories.com.

Location
Moscow, Russia
Analytical partner
Novosibirsk Analytics, independent laboratory
Product range
Catalogue 2026 — 8 families, 42 items
Working languages
English, Russian
Contact
info@novagenixlaboratories.com
Novagenix vials on the shelf of a freeze-dryer
Filled vials on a freeze-dryer shelf

Contact the laboratory

Distribution, certificates and analytical questions. We answer in English and Russian.

Details

Email
info@novagenixlaboratories.com
Location
Moscow, Russia
Subjects
Distribution enquiries · certificates of analysis · seller verification · analytical questions
Working languages
English, Russian